Combined bulk RNA and single-cell RNA analyses reveal TXNL4A as a new biomarker for hepatocellular carcinoma.
Frontiers in oncology（2023）
摘要
Therefore, we identified a prognostic and immune-related marker for HCC from the RNA splicing pathway.
更多查看译文
关键词
hepatocellular carcinoma,combined bulk rna,txnl4a,single-cell
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要